Related Experiment Video
Updated: May 10, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
Endovascular techniques in limb salvage: infrapopliteal angioplasty
Joseph J Naoum1, Elias J Arbid
1The Methodist Hospital, Houston, Texas, USA.
Insights
Endovascular treatment for critical limb ischemia (CLI) is a safe and effective option, particularly for high-risk patients. Revascularizing affected arteries improves wound healing and reduces amputations.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Peripheral Artery Disease
Background:
- Critical limb ischemia (CLI) stems from insufficient blood flow to extremities.
- Infragenicular atherosclerosis is a primary cause, often linked to diffuse arterial disease and poor foot perfusion.
- Endovascular therapies are increasingly favored over open surgery for CLI, especially in high-risk individuals.
Purpose of the Study:
- To evaluate the efficacy and safety of endovascular treatment for CLI.
- To highlight the benefits of revascularizing below-the-knee arteries.
- To explore the role of angiosome-targeted revascularization and drug-coated balloons (DCB) in improving outcomes.
Main Methods:
- Review of endovascular treatment options for CLI.
- Analysis of outcomes for endovascular recanalization of below-the-knee arteries.
- Consideration of angiosome-specific revascularization strategies.
- Evaluation of drug-coated balloons (DCB) in angioplasty procedures.
Main Results:
- Endovascular recanalization of below-the-knee arteries is feasible and safe.
- This approach reduces amputation rates and enhances wound healing.
- Angiosome-targeted revascularization may optimize treatment efficacy.
- Drug-coated balloons (DCB) show potential for improved patency rates compared to standard angioplasty.
Conclusions:
- Endovascular therapy is a viable and effective primary strategy for CLI.
- Targeted revascularization and advanced technologies like DCB offer improved outcomes for CLI patients.
- These minimally invasive techniques are crucial in limb salvage and improving quality of life.
Abstract:
Critical limb ischemia (CLI) results from inadequate blood flow to supply and sustain the metabolic needs of resting muscle and tissue. Infragenicular atherosclerosis is the most common cause of CLI, and it is more likely to develop when multilevel or diffuse arterial disease coincides with compromised run-off to the foot. Reports of good technical and clinical outcomes have advanced the endovascular treatment options, which have gained a growing acceptance as the primary therapeutic strategy for CLI, especially in patients with significant risk factors for open surgical bypass. In fact, endovascular recanalization of below-the-knee arteries has proven to be feasible and safe, reduce the need for amputation, and improve wound healing. The distribution of various vascular territories or angiosomes in the foot has been recognized, and it appears advantageous to revascularize the artery supplying the territory directly associated with tissue loss. In addition, the targeted application and local delivery of drugs using drug-coated balloons (DCB) during angioplasty has the potential to improve patency rates compared to balloon angioplasty alone.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
